Money and Finance
If you take a look at my portfolio I'm lacking in two major areas that I'd like to get more exposure too. One is the food industry, I only have KO and MCD that are direct plays on food and the other is healthcare. The demographics both in the United States and globally is trending towards an older population which generally means more healthcare services. Today I'm going to take a closer look at Baxter Intenational, Inc. BAX closed trading on Tuesday, August 27th at $70.60.
Company Background (sourced from Yahoo! Finance):
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.
Read more »
- Johnson And Johnson Dividend Stock Analysis
I've been meaning to revisit my analysis on Johnson and Johnson since it's been a year since I first looked at them. I've learned so much more about stock analysis in that time so this will be more thorough and hopefully more insightful....
- Medtronic Stock Analysis
Like my Coca-Cola stock analysis I was surprised when I looked back through my stock analysis archives that I had never posted about Medtronic (MDT). I had actually gone through the full analysis back in June of this year but couldn't find my post...
- Becton Dickinson Stock Analysis
Since I'm really lacking on health care industry exposure it was time to start looking at some of the different companies, so today we'll look at Becton Dickinson and Company. Becton Dickinson closed trading on Monday, November 5th at $76.59....
- Walgreen's Stock Analysis
I've been meaning to post some more stock analysis' so today we'll look at one of my recent buy's, Walgreen's. On Friday, November 2nd, Walgreen's closed at $34.88. Company Background: Walgreen Co., together with its subsidiaries,...
- Recent Buy
I just added 14 shares of BAX for a grand cost of $1001.00 ($71/share+7 trading fee). This adds $29.12 to my forward annual dividend. I am still strengthening the core of my portfolio as this is my one and only health care (until JNJ comes down to earth)....
Money and Finance
Baxter International (BAX) - Dividend Stock Analysis
If you take a look at my portfolio I'm lacking in two major areas that I'd like to get more exposure too. One is the food industry, I only have KO and MCD that are direct plays on food and the other is healthcare. The demographics both in the United States and globally is trending towards an older population which generally means more healthcare services. Today I'm going to take a closer look at Baxter Intenational, Inc. BAX closed trading on Tuesday, August 27th at $70.60.
Company Background (sourced from Yahoo! Finance):
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.
Read more »
- Johnson And Johnson Dividend Stock Analysis
I've been meaning to revisit my analysis on Johnson and Johnson since it's been a year since I first looked at them. I've learned so much more about stock analysis in that time so this will be more thorough and hopefully more insightful....
- Medtronic Stock Analysis
Like my Coca-Cola stock analysis I was surprised when I looked back through my stock analysis archives that I had never posted about Medtronic (MDT). I had actually gone through the full analysis back in June of this year but couldn't find my post...
- Becton Dickinson Stock Analysis
Since I'm really lacking on health care industry exposure it was time to start looking at some of the different companies, so today we'll look at Becton Dickinson and Company. Becton Dickinson closed trading on Monday, November 5th at $76.59....
- Walgreen's Stock Analysis
I've been meaning to post some more stock analysis' so today we'll look at one of my recent buy's, Walgreen's. On Friday, November 2nd, Walgreen's closed at $34.88. Company Background: Walgreen Co., together with its subsidiaries,...
- Recent Buy
I just added 14 shares of BAX for a grand cost of $1001.00 ($71/share+7 trading fee). This adds $29.12 to my forward annual dividend. I am still strengthening the core of my portfolio as this is my one and only health care (until JNJ comes down to earth)....